Cargando...
Enhancing Dendritic Cell Therapy in Solid Tumors with Immunomodulating Conventional Treatment
Dendritic cells (DCs) are the most potent antigen-presenting cells and are the key initiator of tumor-specific immune responses. These characteristics are exploited by DC therapy, where DCs are ex vivo loaded with tumor-associated antigens (TAAs) and used to induce tumor-specific immune responses. U...
Gardado en:
| Publicado en: | Mol Ther Oncolytics |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
American Society of Gene & Cell Therapy
2019
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6475716/ https://ncbi.nlm.nih.gov/pubmed/31020037 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.omto.2019.03.007 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|